Molecule Details
| InChIKey | QMUSHXFQMCVHRH-LVWCRJLFSA-N |
|---|---|
| Compound Name | (S)-2-{2-[((S)-2-{2-[3-((E)-3,7-Dimethyl-octa-2,6-dienyl)-3H-imidazol-4-yl]-acetylamino}-3-methyl-pentyl)-naphthalen-1-ylmethyl-amino]-acetylamino}-4-methylsulfanyl-butyric acid |
| Canonical SMILES | CCC(C)[C@@H](CN(CC(=O)N[C@@H](CCSC)C(=O)O)Cc1cccc2ccccc12)NC(=O)Cc1cncn1C/C=C(\C)CCC=C(C)C |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 9.39 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile